Bill > HR4093

This bill, the Remote Opioid Monitoring Act of 2023, requires the Comptroller General of the United States to conduct a study and submit a report to Congress on the use of remote monitoring for individuals who are prescribed opioids. The report will assess the scientific evidence related to the efficacy, individual outcomes, and potential cost savings of remote monitoring for these individuals, as well as the current prevalence of such monitoring, including its use in other countries. The report will also provide recommendations to improve the availability, access, and coverage of remote monitoring for individuals prescribed opioids, including through changes to federal healthcare programs.